Performance of the DecisionDx-Melanoma Gene Expression Profile Test for Prognosis of Recurrence Risk
Objective
Primary Endpoint: To further evaluate the performance of DecisionDx-Melanoma in specific cohorts of subjects with primary cutaneous melanoma, including subjects with thin tumors less than 1mm in thickness with subsequent metastasis, and those with tumors identified as substage IIA, IIB, IIC, IIIA, IIIB, or IIIC.
